Metoprolol is a selective beta-1 blocker commonly employed as the succinate and tartrate derivatives depending if the formulation is designed to be of immediate release or extended release. The possibility of the generation of these formulations comes from the lower systemic bioavailability of the succinate derivative. To this date, it is one of the preferre...
Metoprolol is indicated for the treatment of angina, heart failure, myocardial infarction, atrial fibrillation, atrial flutter and hypertension.
Some off-label uses of metoprolol include supraventricular tachycardia and thyroid storm.
...
Federico II University of Naples, Naples, Italy
State Research Institute of CIrculation Pathology Novosibirsk, Russian Federation, Novosibirsk, Russian Federation
Research Clinical Institute of Pediatrics, N.I. Pirogov Russian National Research Medical University, Moscow, Russian Federation
Boehringer Ingelheim Investigational Site, Berlin, Germany
Barnes-Jewish Hospital/Washington University in St. Louis School of Medicine, Saint Louis, Missouri, United States
Vestre Viken Hospital Trust, Baerum Hospital, Rud, Akershus, Norway
Regeneron Study Site, Raleigh, North Carolina, United States
Twenty-four-hour ambulatory BP monitoring, Budapest, Hungary
Recep Tayyip Erdogan University, Rize, Eastern Blacksea, Turkey
Portable polysomnography, Suzhou, Jiangsu, China
Twenty-four-hour ambulatory BP monitoring, Budapest, Hungary
Teutori CPRU, Turku, Finland
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.